Peter J Hoskin

Peter J Hoskin

UNVERIFIED PROFILE

Are you Peter J Hoskin?   Register this Author

Register author
Peter J Hoskin

Peter J Hoskin

Publications by authors named "Peter J Hoskin"

Are you Peter J Hoskin?   Register this Author

100Publications

1832Reads

47Profile Views

External beam radiotherapy (EBRT) and high-dose rate (HDR) brachytherapy for intermediate and high-risk prostate cancer: the impact of EBRT volume.

Int J Radiat Oncol Biol Phys 2019 Oct 11. Epub 2019 Oct 11.

Mount Vernon Cancer Centre, Northwood, UK; University of Manchester, Manchester, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2019.09.044DOI Listing
October 2019

Organ preservation in bladder cancer: an opportunity for truly personalized treatment.

Nat Rev Urol 2019 Sep 13;16(9):511-522. Epub 2019 Jun 13.

Manchester Cancer Research Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41585-019-0199-xDOI Listing
September 2019

New approaches for effective and safe pelvic radiotherapy in high-risk prostate cancer.

Nat Rev Urol 2019 Sep 25;16(9):523-538. Epub 2019 Jul 25.

Mount Vernon Cancer Centre, Northwood, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41585-019-0213-3DOI Listing
September 2019

Hypoxia and angiogenic biomarkers in prostate cancer after external beam radiotherapy (EBRT) alone or combined with high-dose-rate brachytherapy boost (HDR-BTb).

Radiother Oncol 2019 Aug 3;137:38-44. Epub 2019 May 3.

Mount Vernon Cancer Centre, Northwood, United Kingdom; University of Manchester, Manchester, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2019.04.019DOI Listing
August 2019

Single Fraction High-Dose-Rate Brachytherapy: Too Good to Be True?

Int J Radiat Oncol Biol Phys 2019 Aug;104(5):1054-1056

Mount Vernon Hospital, Northwood, Middlesex, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2019.04.036DOI Listing
August 2019

Predictive Biomarkers for Muscle-invasive Bladder Cancer: The Search for the Holy Grail Continues.

Eur Urol 2019 Jul 4;76(1):69-70. Epub 2019 Feb 4.

Manchester Cancer Research Centre, Division of Cancer Science, School of Medical Sciences, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2019.01.040DOI Listing
July 2019

Outcomes of radiosensitisation in elderly patients with advanced bladder cancer.

Radiother Oncol 2018 12 2;129(3):499-506. Epub 2018 Jun 2.

Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, United Kingdom; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01678140183028
Publisher Site
http://dx.doi.org/10.1016/j.radonc.2018.05.022DOI Listing
December 2018

Focal boost to residual gross tumor volume in brachytherapy for cervical cancer-A feasibility study.

Brachytherapy 2018 Jan - Feb;17(1):181-186. Epub 2017 Nov 15.

Cancer Centre, Mount Vernon Hospital, Northwood, Middlesex, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2017.09.012DOI Listing
July 2018

Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer.

EBioMedicine 2018 May 23;31:182-189. Epub 2018 Apr 23.

Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, Manchester M20 4BX, UK; NIHR Manchester Biomedical Research Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2018.04.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6014579PMC
May 2018

Bladder cancer and the National Cancer Data Base: New insight or misinformation?

Cancer 2018 03 16;124(6):1105-1107. Epub 2018 Jan 16.

Cancer Centre, Mount Vernon Hospital, Northwood, Middlesex, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31210DOI Listing
March 2018

The optimism surrounding stereotactic body radiation therapy and immunomodulation.

Chin Clin Oncol 2017 Sep;6(Suppl 2):S9

Mount Vernon Cancer Centre, Northwood, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/cco.2017.05.01DOI Listing
September 2017

A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High-Risk Bladder Cancer Patients.

Clin Cancer Res 2017 Aug 11;23(16):4761-4768. Epub 2017 Apr 11.

Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, Manchester, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-0038DOI Listing
August 2017

The dosimetric impact of air in vaginal vault brachytherapy.

Brachytherapy 2016 Nov - Dec;15(6):832-838. Epub 2016 Sep 29.

Cancer Centre, Mount Vernon Hospital, Middlesex, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2016.08.006DOI Listing
July 2017

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.

N Engl J Med 2017 07 3;377(4):338-351. Epub 2017 Jun 3.

From the Institute of Cancer and Genomic Sciences, University of Birmingham (N.D.J.), and University Hospital Birmingham (A.Z.), Birmingham, the Institute of Cancer Research (J.S.B., D.P.D., G.A.), Medical Research Council Clinical Trials Unit at University College London (M.R. Spears, C.L.A., C.G., C.B., M.K.B.P., M.R. Sydes), King's College London and Guy's and St. Thomas' NHS Foundation Trust (S.C.), and Royal Marsden NHS Foundation Trust (C.C.P.), London, Salford Royal NHS Foundation Trust, Salford (N.W.C.), Cardiff University School of Medicine (M.D.M.) and Velindre Cancer Centre (J.F.L.), Cardiff, Gloucestershire Royal Hospital (A.W.S.R.) and Gloucestershire Hospitals NHS Foundation Trust (J.B.), Gloucester, University of Glasgow, Glasgow (R.J.J., J.M.R.), St. James's University Hospital, Leeds (W.R.C.), University Hospital of North-Midlands, Stoke-on-Trent (F.A.), Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter (S.A.), Rosemere Cancer Centre, Royal Preston Hospital, Preston (A.J.B.), Dorset Cancer Centre, Poole Hospital, Poole (S.B.), Royal Derby Hospital, Derby (P.C.), Weston Park Hospital, Sheffield (C.F.), Portsmouth Oncology Centre, Queen Alexandra Hospital, Portsmouth (J.G.), Musgrove Park Hospital, Taunton (E.G.), Hull and East Yorkshire Hospitals NHS Trust, Hull (M.H.), Mount Vernon Cancer Centre, Northwood (P.J.H.), Clatterbridge Cancer Centre, Wirral (Z.I.M.), Brighton and Sussex University Hospitals NHS Trust (F.M.) and Sussex Cancer Centre, Royal Sussex County Hospital (A.R.), Brighton, NHS Highland, Inverness (N.M.), Royal Surrey County Hospital, Guildford (J.M.-K.), Northern Ireland Cancer and Queens University, Belfast (J.O.), Lancashire Teaching Hospitals NHS Trust, Preston (O.P.), Churchill Hospital, Oxford (A.P.), Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury (N.N.S.), East Kent Hospitals NHS Trust, Canterbury (C.T.), Swansea University College of Medicine, Swansea (J. Wagstaff), and Christie NHS Foundation Trust, Manchester (J. Wylie) - all in the United Kingdom; and the Department of Medical Oncology, Kantonsspital St. Gallen, St. Gallen (S.G.), and University Hospital of Lausanne, Lausanne (D.R.B.) - both in Switzerland. Two of the authors (D.M., R.M.) were unaffiliated lay members of the STAMPEDE investigators.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1702900DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533216PMC
July 2017

Treat All Known Disease.

Authors:
Peter J Hoskin

Int J Radiat Oncol Biol Phys 2017 07;98(3):494

Mount Vernon Cancer Centre, Northwood, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2016.12.006DOI Listing
July 2017

The evolution of brachytherapy for prostate cancer.

Nat Rev Urol 2017 Jun;14(7):415-439

Department of Radiation Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, Pennsylvania 19111-2497, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrurol.2017.76DOI Listing
June 2017

Hypoxia dose painting in prostate and cervix cancer.

Authors:
Peter J Hoskin

Acta Oncol 2015 6;54(9):1259-62. Epub 2015 Jul 6.

a Mount Vernon Cancer Centre , Northwood , UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/0284186X.2015.1061692DOI Listing
August 2016

Randomized Double-Blind Trial of Pregabalin Versus Placebo in Conjunction With Palliative Radiotherapy for Cancer-Induced Bone Pain.

J Clin Oncol 2016 Feb 7;34(6):550-6. Epub 2015 Dec 7.

Marie Fallon and Barry J.A. Laird, Edinburgh Cancer Research Centre, University of Edinburgh; Lesley A. Colvin, Western General Hospital and University of Edinburgh; Susan M. Fleetwood-Walker, School of Biomedical Sciences, University of Edinburgh; Gordon D. Murray, Centre for Population Health Sciences, University of Edinburgh, Edinburgh; Peter J. Hoskin, Mount Vernon Hospital Cancer Centre, Middlesex, and University College London; Douglas Adamson, Princess Alexandra Centre, Ninewells Hospital, Dundee; Anthony Byrne, Marie Curie Palliative Care Research Centre, Institute of Cancer and Genetics, Cardiff University, Cardiff, United Kingdom; and Barry J.A. Laird, European Palliative Care Research Centre, Norwegian University of Science and Technology, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.8221DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098845PMC
February 2016

A Delphi consensus study on salvage brachytherapy for prostate cancer relapse after radiotherapy, a Uro-GEC study.

Radiother Oncol 2016 Jan 5;118(1):122-30. Epub 2015 Nov 5.

Mount Vernon Cancer Centre, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2015.10.021DOI Listing
January 2016

Protons and more: state of the art in radiotherapy.

Clin Med (Lond) 2014 Dec;14 Suppl 6:s61-5

Mount Vernon Cancer Centre, Middlesex, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7861/clinmedicine.14-6-s61DOI Listing
December 2014

Risk of premature menopause after treatment for Hodgkin's lymphoma.

J Natl Cancer Inst 2014 Sep 19;106(9). Epub 2014 Aug 19.

Divisions of Genetics and Epidemiology (AJS, RC), Breast Cancer Research (AJS) and Radiotherapy (AH), Institute of Cancer Research, Sutton, UK; University of Manchester and Christie NHS Foundation Trust, Manchester, UK (JR); Gastrointestinal Unit, Royal Marsden Hospital, Sutton, UK (DC); Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK (IS); Cancer Research UK Medical Oncology Unit, St. Bartholomew's Hospital, London, UK (TAL); Cancer Centre, Mount Vernon Hospital, Middlesex, UK (PJH); St. James Institute of Oncology, Leeds, UK (DG); Northern Centre for Cancer Care, Freeman Hospital, Newcastle, UK (HHL); Bristol Haematology and Oncology Centre, Bristol, UK (SJF); Addenbrooke's Hospital, Cambridge, UK (MVW); Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, UK (BWH); Guy's and St. Thomas, London, UK (SJH); Department of Haematology, University College Hospital, London, UK (DCL); Southampton General Hospital, Southampton, UK (AB); Queen Elizabeth Hospital, Birmingham, UK (AMS). The England and Wales Hodgkin Lymphoma Follow-up Group includes the authors of this article plus: Gabriel Anghel, Lincoln Hospital; Brian Attock, North Devon District Hospital; Jane Barrett, Royal Berkshire Hospital; Andrew Bell, Poole Hospital; Kim Benstead, Cheltenham General Hospital; Eric M. Bessell, Nottingham University Hospital; Ashoke Biswas, Royal Preston Hospital; Norbert Blesing, Great Western Hospital, Swindon; Caroline Brammer, New Cross Hospital, Wolverhampton; Jill Brock, Clatterbridge Centre for Oncology; Alison Brownell, Queens Hospital, Romford; A. Murray Brunt, University Hospital of North Staffordshire; Peter B. Coates, Queen Elizabeth Hospital, King's Lynn; Matthew P. Collinson, Royal Cornwall Hospital; Neville Davidson, Essex County Hospital; Sian Davies, North Middlesex University Hospital; Ian Fentiman, Guy's Hospital; Eve Gallop-Evans, Velindre Hospital; Angel Garcia, Glan Clwyd Hospital; Andrew Goodman, Royal Devon and Exeter Hospital; Ad

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju207DOI Listing
September 2014

Guidelines for the first line management of classical Hodgkin lymphoma.

Br J Haematol 2014 Jul 9;166(1):34-49. Epub 2014 Apr 9.

Department of Haematology, Addenbrookes Hospital, Cambridge University Teaching Hospitals, Cambridge, UK.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bjh.12878
Publisher Site
http://dx.doi.org/10.1111/bjh.12878DOI Listing
July 2014

Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial.

Radiother Oncol 2013 Jul 14;108(1):40-7. Epub 2013 Jun 14.

Translational Radiobiology Group, Institute of Cancer Sciences, The University of Manchester, Manchester Academic Health Centre, Christie Hospital, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2013.05.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3885794PMC
July 2013

Critical structure movement in cervix brachytherapy.

Radiother Oncol 2013 Apr 22;107(1):39-45. Epub 2013 Feb 22.

Mount Vernon Cancer Centre, Northwood, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2013.01.006DOI Listing
April 2013

FTIR microspectroscopy of selected rare diverse sub-variants of carcinoma of the urinary bladder.

J Biophotonics 2013 Jan 2;6(1):73-87. Epub 2012 Nov 2.

Manchester Institute of Biotechnology, University of Manchester, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jbio.201200126DOI Listing
January 2013

Non-small cell lung cancer: histopathologic correlates for texture parameters at CT.

Radiology 2013 Jan 20;266(1):326-36. Epub 2012 Nov 20.

Clinical Imaging Sciences Centre, Brighton and Sussex Medical School, University of Sussex, Brighton, England.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.12112428DOI Listing
January 2013

Image-guided vulvovaginal interstitial brachytherapy in the treatment of primary and recurrent gynecological malignancies.

Brachytherapy 2012 Jul-Aug;11(4):306-10. Epub 2011 Oct 12.

Mount Vernon Cancer Centre, Rickmansworth Road, Northwood, Middlesex, United Kingdom.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S153847211100361
Publisher Site
http://dx.doi.org/10.1016/j.brachy.2011.08.002DOI Listing
November 2012

Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort study.

J Clin Oncol 2011 Nov 3;29(31):4096-104. Epub 2011 Oct 3.

Section of Epidemiology, Sir Richard Doll Building, Institute of Cancer Research, Sutton, Surrey SM2 5NG, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.34.8268DOI Listing
November 2011

Validation of a score predicting post-treatment ambulatory status after radiotherapy for metastatic spinal cord compression.

Int J Radiat Oncol Biol Phys 2011 Apr 3;79(5):1503-6. Epub 2010 Jun 3.

Department of Radiation Oncology, University Hospital Schleswig-Holstein, Lubeck, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2010.01.024DOI Listing
April 2011

Radiotherapy with concurrent carbogen and nicotinamide in bladder carcinoma.

J Clin Oncol 2010 Nov 18;28(33):4912-8. Epub 2010 Oct 18.

Cancer Centre, Mount Vernon Hospital, Northwood, Middlesex, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.28.4950DOI Listing
November 2010

High-dose-rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma.

Brachytherapy 2010 Jan-Mar;9(1):66-70. Epub 2009 Oct 20.

Mount Vernon Cancer Centre, Rickmansworth Road, Middlesex, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2009.07.004DOI Listing
April 2010

I-125 seed planning: an alternative method of urethra definition.

Radiother Oncol 2010 Jan 11;94(1):24-9. Epub 2009 Dec 11.

Clinical Physics Department, Mount Vernon Cancer Centre, Middlesex HA6 2RN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2009.11.003DOI Listing
January 2010

Effect of epoetin alfa on survival and cancer treatment-related anemia and fatigue in patients receiving radical radiotherapy with curative intent for head and neck cancer.

J Clin Oncol 2009 Dec 2;27(34):5751-6. Epub 2009 Nov 2.

Marie Curie Research Wing for Oncology, Mount Vernon Centre for Cancer Treatment, Mount Vernon Hospital, Northwood, Middlesex, UK.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2009.22.3693
Publisher Site
http://dx.doi.org/10.1200/JCO.2009.22.3693DOI Listing
December 2009

Non-surgical treatment of localised prostate cancer.

Surg Oncol 2009 Sep 12;18(3):255-67. Epub 2009 May 12.

Mount Vernon Hospital, Mount Vernon Cancer Centre, Northwood, Middlesex HA9 2RN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.suronc.2009.03.006DOI Listing
September 2009

Carbogen and nicotinamide in locally advanced bladder cancer: early results of a phase-III randomized trial.

Radiother Oncol 2009 Apr 5;91(1):120-5. Epub 2008 Nov 5.

CR-UK Tumour Biology and Radiation Research Group, Northwood, Middlesex, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2008.10.001DOI Listing
April 2009

Dosimetry and field matching for radiotherapy to the breast and supraclavicular fossa.

Radiother Oncol 2009 Apr 3;91(1):42-8. Epub 2009 Feb 3.

Department of Radiography, City University, Northampton Square, London EC1V 0HB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2008.11.016DOI Listing
April 2009

A score predicting posttreatment ambulatory status in patients irradiated for metastatic spinal cord compression.

Int J Radiat Oncol Biol Phys 2008 Nov 23;72(3):905-8. Epub 2008 Apr 23.

Department of Radiation Oncology, University Hospital Schleswig-Holstein, Luebeck, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2008.02.018DOI Listing
November 2008

Vaginal vault brachytherapy as sole postoperative treatment for low-risk endometrial cancer.

Brachytherapy 2008 Apr-Jun;7(2):195-9. Epub 2008 Mar 20.

Mount Vernon Cancer Centre, Northwood, Middlesex, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2008.01.001DOI Listing
September 2008

Prognostic factors for functional outcome and survival after reirradiation for in-field recurrences of metastatic spinal cord compression.

Cancer 2008 Sep;113(5):1090-6

Department of Radiation Oncology, University Hospital Schleswig-Holstein, Luebeck, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.23702
Publisher Site
http://dx.doi.org/10.1002/cncr.23702DOI Listing
September 2008

Improved posttreatment functional outcome is associated with better survival in patients irradiated for metastatic spinal cord compression.

Int J Radiat Oncol Biol Phys 2007 Apr 1;67(5):1506-9. Epub 2007 Feb 1.

Department of Radiation Oncology, University Hospital Schleswig-Holstein, Lübeck, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2006.11.029DOI Listing
April 2007

Tumor antivascular effects of radiotherapy combined with combretastatin a4 phosphate in human non-small-cell lung cancer.

Int J Radiat Oncol Biol Phys 2007 Apr 1;67(5):1375-80. Epub 2007 Feb 1.

Marie Curie Research Wing, Mount Vernon Hospital, Middlesex, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2006.11.028DOI Listing
April 2007

Functional outcome and survival after radiotherapy of metastatic spinal cord compression in patients with cancer of unknown primary.

Int J Radiat Oncol Biol Phys 2007 Feb 2;67(2):532-7. Epub 2006 Nov 2.

Department of Radiation Oncology, University Hospital Schleswig-Holstein, Luebeck, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2006.08.047DOI Listing
February 2007

Escalation of radiation dose beyond 30 Gy in 10 fractions for metastatic spinal cord compression.

Int J Radiat Oncol Biol Phys 2007 Feb 4;67(2):525-31. Epub 2006 Dec 4.

Department of Radiation Oncology, University Hospital Schleswig-Holstein, Luebeck, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2006.09.025DOI Listing
February 2007

Radiotherapy of metastatic spinal cord compression in very elderly patients.

Int J Radiat Oncol Biol Phys 2007 Jan;67(1):256-63

Department of Radiation Oncology, University Hospital Schleswig-Holstein, Luebeck, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2006.08.011DOI Listing
January 2007

Is short-course radiotherapy with high doses per fraction the appropriate regimen for metastatic spinal cord compression in colorectal cancer patients?

Strahlenther Onkol 2006 Dec;182(12):708-12

Department of Radiation Oncology, University Hospital Schleswig Holstein, Campus Luebeck, Luebeck, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00066-006-1578-9DOI Listing
December 2006

Quantitative assessment of lung cancer perfusion using MDCT: does measurement reproducibility improve with greater tumor volume coverage?

AJR Am J Roentgenol 2006 Oct;187(4):1079-84

Marie Curie Research Wing, Mount Vernon Hospital, Northwood, Middlesex, United Kingdom.

View Article

Download full-text PDF

Source
http://www.ajronline.org/doi/10.2214/AJR.05.0889
Publisher Site
http://dx.doi.org/10.2214/AJR.05.0889DOI Listing
October 2006

Innovative technologies in radiation therapy: brachytherapy.

Semin Radiat Oncol 2006 Oct;16(4):209-17

Mount Vernon Cancer Centre, Middlesex, United Kingdom.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10534296060002
Publisher Site
http://dx.doi.org/10.1016/j.semradonc.2006.04.003DOI Listing
October 2006

Lung cancer perfusion at multi-detector row CT: reproducibility of whole tumor quantitative measurements.

Radiology 2006 May 16;239(2):547-53. Epub 2006 Mar 16.

Marie Curie Research Wing and Paul Strickland Scanner Centre, Mount Vernon Hospital, Rickmansworth Rd, Northwood, Middlesex, England.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2392050568DOI Listing
May 2006

An immunohistochemical assessment of hypoxia in prostate carcinoma using pimonidazole: implications for radioresistance.

Int J Radiat Oncol Biol Phys 2006 May 24;65(1):91-9. Epub 2006 Mar 24.

Marie Curie Research Wing, Mount Vernon Hospital, Northwood, Middlesex, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2005.11.044DOI Listing
May 2006

Defining the appropriate radiotherapy regimen for metastatic spinal cord compression in non-small cell lung cancer patients.

Eur J Cancer 2006 May 31;42(8):1052-6. Epub 2006 Mar 31.

Department of Radiation Oncology, University Medical Center Hamburg Eppendorf, University Hospital Hamburg, Martinistr. 52, D-20246 Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2005.12.022DOI Listing
May 2006

Short-course radiotherapy is not optimal for spinal cord compression due to myeloma.

Int J Radiat Oncol Biol Phys 2006 Apr 18;64(5):1452-7. Epub 2006 Jan 18.

Department of Radiation Oncology, University Hospital, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2005.10.018DOI Listing
April 2006

Risk of second malignancy after non-Hodgkin's lymphoma: a British Cohort Study.

J Clin Oncol 2006 Apr 6;24(10):1568-74. Epub 2006 Mar 6.

Section of Epidemiology, Institute of Cancer Research, Sutton, Surrey, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.04.2200DOI Listing
April 2006

Evaluation of functional outcome and local control after radiotherapy for metastatic spinal cord compression in patients with prostate cancer.

J Urol 2006 Feb;175(2):552-6

Department of Radiation Oncology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0022-5347(05)00241-7DOI Listing
February 2006

Prognostic factors predicting functional outcomes, recurrence-free survival, and overall survival after radiotherapy for metastatic spinal cord compression in breast cancer patients.

Int J Radiat Oncol Biol Phys 2006 Jan 28;64(1):182-8. Epub 2005 Sep 28.

Department of Radiation Oncology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2005.06.036DOI Listing
January 2006

Spinal reirradiation after short-course RT for metastatic spinal cord compression.

Int J Radiat Oncol Biol Phys 2005 Nov 4;63(3):872-5. Epub 2005 Jun 4.

Department of Radiation Oncology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2005.03.034DOI Listing
November 2005

Cervical brachytherapy utilizing ring applicator: comparison of standard and conformal loading.

Int J Radiat Oncol Biol Phys 2005 Nov;63(3):934-9

Mount Vernon Cancer Center, Northwood, Middlesex, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2005.07.963DOI Listing
November 2005

[Effectiveness and toxicity of reirradiation (Re-RT) for metastatic spinal cord compression (MSCC)].

Strahlenther Onkol 2005 Sep;181(9):595-600

Klinik und Poliklinik für Strahlentherapie und Radioonkologie, Universitätsklinikum, Hamburg Eppendorf.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00066-005-1406-7
Publisher Site
http://dx.doi.org/10.1007/s00066-005-1406-7DOI Listing
September 2005

Acute and late morbidity in the treatment of advanced bladder carcinoma with accelerated radiotherapy, carbogen, and nicotinamide.

Cancer 2005 Jun;103(11):2287-97

Cancer Research-UK Tumor Biology and Radiation Research Group, Marie Curie Research Wing, Mount Vernon Hospital, Northwood, Middlesex, United Kingdom.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.21048
Publisher Site
http://dx.doi.org/10.1002/cncr.21048DOI Listing
June 2005

Radioisotopes for metastatic bone pain.

Authors:
Peter J Hoskin

Lancet Oncol 2005 Jun;6(6):353-4

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(05)70179-0DOI Listing
June 2005

High dose rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma.

Radiother Oncol 2004 Nov;73(2):195-8

Mount Vernon Cancer Centre, Mount Vernon Hospital, Rickmansworth Road, Northwood, Middlesex HA6 2RN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2004.06.004DOI Listing
November 2004

The immunohistochemical assessment of hypoxia, vascularity and proliferation in bladder carcinoma.

Radiother Oncol 2004 Aug;72(2):159-68

CR UK Tumour Biology and Radiation Therapy Group, Mount Vernon Cancer Centre, Rickmansworth Road, Northwood, Middlesex HA6 2RN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2004.03.017DOI Listing
August 2004

The use of in vivo thermoluminescent dosimeters in the quality assurance programme for the START breast fractionation trial.

Radiother Oncol 2004 Jun;71(3):303-10

Marie Curie Research Wing, Mount Vernon Hospital, Rickmansworth Road, Northwood, Middlesex HA6 2RN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2004.02.008DOI Listing
June 2004

Target validation of cytochrome P450 CYP1B1 in prostate carcinoma with protein expression in associated hyperplastic and premalignant tissue.

Int J Radiat Oncol Biol Phys 2004 Feb;58(2):500-9

Marie Curie Research Wing, Gray Cancer Institute, Mount Vernon Hospital, Northwood, Middlesex HA6 2JR, United Kingdom

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2003.09.064DOI Listing
February 2004

High dose rate afterloading brachytherapy for prostate cancer: catheter and gland movement between fractions.

Radiother Oncol 2003 Sep;68(3):285-8

Mount Vernon Cancer Centre, Rickmansworth Road, Northwood, Middlesex HA6 2RN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0167-8140(03)00203-2DOI Listing
September 2003

Metastatic spinal cord compression: radiotherapy outcome and dose fractionation.

Radiother Oncol 2003 Aug;68(2):175-80

Mount Vernon Centre for Cancer Treatment, Rickmansworth Road, Northwood, Middlesex HA6 2RN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0167-8140(03)00191-9DOI Listing
August 2003